EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tau pathology is associated with postsynaptic metabotropic glutamate receptor 5 (mGluR5) in early Alzheimer's disease in a sex‐specific manner

Yan Wang, Jie Wang, Xing Chen, Zengping Lin, Zhiwen You, Kun He, Tengfei Guo, Jun Zhao, Qi Huang, Ruiqing Ni, Yihui Guan, Binyin Li und 1 weitere

Alzheimer's & Dementia · 2025

DOI: 10.1002/alz.70004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Yan Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine & PET Center, Huashan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Receptor, Metabotropic Glutamate 5, Alzheimer Disease, tau Proteins, Hippocampus. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: STI2030-Major Projects, National Science Foundation of China, Shanghai Sailing Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION To investigate the associations of metabotropic glutamate receptor 5 (mGluR5) with tau deposition and cognitive ability in patients with early Alzheimer's disease (AD). METHODS Twenty‐six cognitively impaired (CI) and 14 cognitively unimpaired (CU) individuals underwent mGluR5 positron emission tomography (PET) ([ 18 F]PSS232), amyloid PET ([ 18 F]florbetapir), and tau PET ([ 18 F]MK6240), and neuropsychological assessment. The relationships among mGluR5 availability, tau deposition, and neuropsychological assessment were analyzed using Spearman's correlation and mediation analyses. RESULTS CI patients had lower mGluR5 in the hippocampus than CU (standardized uptake value ratio [SUVr]: 2.03 ± 0.25 vs 1.79 ± 0.17, p = 0.003). Hippocampal mGluR5 was negatively associated with hippocampal tau deposition ( r = −.46, p = 0.003) and positively associated with cognitive performance, but only in women. Hippocampal tau deposition mediated the effect of mGluR5 on cognitive performance. DISCUSSION Reduced hippocampal mGluR5 is negatively related with tau deposition in most cortical regions and positively associated with cognitive performance, making it a promising biomarker for AD diagnosis and therapy. Highlights Cognitively impaired (CI) patients exhibited lower metabotropic glutamate receptor 5 (mGluR5) availability in the hippocampus than cognitively unimpaired (CU) subjects. Hippocampal mGluR5 availability was negatively associated with tau deposition in widespread cortex. Hippocampal mGluR5 availability was positively associated with cognitive performance. The close association of mGluR5 with tau and cognition performance exists only in females. Tau pathology mediated the relationship between mGluR5 availability and cognition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Metabotropic Glutamate 5Alzheimer Diseasetau ProteinsHippocampusCognitive DysfunctionHumansFemaleMalePositron-Emission TomographyAgedNeuropsychological TestsSex FactorsAged, 80 and overMiddle AgedBrain

Stichwörter der Autor:innen

Alzheimer's diseasemetabotropic glutamate receptor 5 (mGluR5)synapsetau

Substanzen

Receptor, Metabotropic Glutamate 5tau ProteinsGRM5 protein, human

Autor:innen und Institutionen

  • Department of Nuclear Medicine & PET Center, Huashan Hospital, Fudan University, Shanghai, China.
  • Department of Nuclear Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
  • Central Research Institute, United Imaging Health Care Group Co., Ltd., Shanghai, China.
  • Institute of Biomedical Engineering, Shenzhen Bay Laboratory, Shenzhen, China.
  • Institute for Biomedical Engineering, Institute for Regenerative Medicine, University of Zurich & ETH Zurich, Zurich, Switzerland.
  • Department of Neurology and Institute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

ORCID-Profile: Fang Xie

Förderung

  • STI2030-Major Projects
  • National Science Foundation of China
  • Shanghai Sailing Program
  • Huashan Hospital, Fudan University
  • Shanghai Municipal Key Clinical Specialty
  • Clinical Research Plan of SHDC
  • Shanghai Municipal Science and Technology Major Project
  • National Natural Science Foundation of China

Zitieren

APA

Wang, Y., Wang, J., Chen, X., Lin, Z., You, Z., He, K., Guo, T., Zhao, J., Huang, Q., Ni, R., Guan, Y., Li, B., & Xie, F. (2025). Tau pathology is associated with postsynaptic metabotropic glutamate receptor 5 (mGluR5) in early Alzheimer's disease in a sex‐specific manner. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70004

Vancouver

Wang Y, Wang J, Chen X, Lin Z, You Z, He K, et al. Tau pathology is associated with postsynaptic metabotropic glutamate receptor 5 (mGluR5) in early Alzheimer's disease in a sex‐specific manner. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70004

BibTeX
@article{Wang2025,
  author = {Wang, Yan and Wang, Jie and Chen, Xing and Lin, Zengping and You, Zhiwen and He, Kun and Guo, Tengfei and Zhao, Jun and Huang, Qi and Ni, Ruiqing and Guan, Yihui and Li, Binyin and Xie, Fang},
  title = {Tau pathology is associated with postsynaptic metabotropic glutamate receptor 5 (mGluR5) in early Alzheimer's disease in a sex‐specific manner},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  doi = {10.1002/alz.70004}
}
Kostenlos starten →